SEC 13F Intelligence

Privium Fund Management B.V. / BIIB

Privium Fund Management B.V.’s Biogen Inc Position

Does Privium Fund Management B.V. own Biogen Inc (BIIB)? Yes — 43.8K shares worth $8M (+1.67% of its 13F portfolio) as of Q1 2026, down from 73.5K shares the prior filed quarter.

Position Value
$8M
Q1 2026
Shares
43.8K
% of Portfolio
+1.67%
Quarters Held
12
currently held

Position History BIIB

Reported value by quarter
Q1 ’22: $3MQ1 ’22Q4 ’22: $750,720Q1 ’23: $1MQ1 ’23Q2 ’23: $1MQ3 ’23: $793,647Q3 ’23Q4 ’23: $1MQ1 ’24: $2MQ1 ’24Q2 ’24: $2MQ2 ’25: $3MQ2 ’25Q3 ’25: $7MQ4 ’25: $13MQ4 ’25Q1 ’26: $8Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 202643.8K$8M+1.67%
Q4 202573.5K$13M+2.38%
Q3 202551.9K$7M+1.31%
Q2 202520.5K$3M+0.58%
Q2 20247.0K$2M+0.41%
Q1 20247.2K$2M+0.41%
Q4 20233.9K$1M+0.29%
Q3 20233.1K$793,647+0.24%
Q2 20233.8K$1M+0.31%
Q1 20233.8K$1M+0.36%
Q4 20222.7K$750,720+0.28%
Q1 202213.4K$3M+0.62%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Privium Fund Management B.V.’s full portfolio or all institutional holders of BIIB.